http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113876775-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2021-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113876775-B |
| titleOfInvention | Use of sinomenine or its pharmaceutically acceptable salt as medicine for treating arterial pulmonary hypertension |
| abstract | The invention discloses the use of sinomenine or a pharmaceutically acceptable salt thereof as a medicine for treating arterial pulmonary hypertension, belongs to the technical field of medicine, and is prepared from sinomenine or a pharmaceutically acceptable salt thereof as an active ingredient and adjuvant The drug used as a drug for the treatment of arterial pulmonary hypertension. The routes of administration of the drug include oral, intramuscular, intravenous, and inhalation. Experiments show that sinomenine has a significant effect on the pulmonary hypertension induced by monocrotaline in rats. |
| priorityDate | 2021-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.